logo
  

Polymetal Q4 Revenue Down On Weak Prices, Backs Production View; Stock Down

Polymetal International plc (POLY.L) reported Thursday that its fourth-quarter revenue declined 6 percent to $798 million from last year's $846 million on the back of lower commodity prices.

Gold equivalent or GE production amounted to 467 thousand ounces, up 24 percent from last year's 377 thousand ounces. The growth was driven by concentrate stockpile release at Kyzyl, high grades at Dukat and first production from Nezhda.

Gold production grew 20 percent and silver production climbed 48 percent in the quarter.

Gold sales dropped 1 percent to 384 thousand ounces, and silver sales declined 7 percent.

For fiscal 2021, revenue edged up 1 percent to $ 2.9 billion with 2 percent rise in GE production of 1.68 million ounces. Gold sales was flat, while silver sales declined.

Looking ahead, the company reiterated its current production guidance of 1.7 Moz of GE for fiscal 2022, and 1.75 Moz of GE for fiscal 2023. Operations in Kazakhstan have not been affected by recent events.

Total Cash Costs or TCC in 2022 is expected to be in the range of $ 850-900/GE oz, approximately 20 percent increase versus 2021.

Capital expenditures in 2022 are expected to be approximately $700 million, a $90 million increase compared to the previous guidance.

In London, Polymetal shares were trading at 1,136.50 pence, down 1.69 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT